✦ LIBER ✦

Donepezil preserves functional status in Alzheimer's disease patients: Results from a 1-year prospective placebo-controlled attrition study

✍ Scribed by R. Mohs; R. Doody; J. Morris; J.R. Ieni; S.L. Rogers; C.A. Perdomo; R.D. Pratt

Book ID: 118601622
Publisher: Elsevier Science
Year: 1999
Tongue: English
Weight: 173 KB
Volume: 9
Category: Article
ISSN: 0924-977X
DOI: 10.1016/s0924-977x(99)80460-x

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

P.4.044 Long-term efficacy of donepezil

P.4.044 Long-term efficacy of donepezil in patients with mild to moderate Alzheimer's disease: Results from a one-year placebo-controlled study and two-year follow-up study

✍ B. Winblad; A. Wimo; A.-L. Wetterholm; A. Haglund; K. Engedal; H. Soininen; F.R. 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 144 KB

Donepezil HCl (E2020) Maintains Function

Donepezil HCl (E2020) Maintains Functional Brain Activity in Patients With Alzheimer Disease: Results of a 24-Week, Double-Blind, Placebo-Controlled Study

✍ Tune, Larry; Tiseo, Paul J.; Ieni, John; Perdomo, Carlos; Pratt, Raymond D.; Vot 📂 Article 📅 2003 🏛 American Psychiatric Publishing Inc 🌐 English ⚖ 793 KB

P.4.041 Donepezil is a well-tolerated lo

P.4.041 Donepezil is a well-tolerated long-term treatment for patients with mild to moderate Alzheimer's disease: Results from a patient cohort who completed a one-year placebo-controlled study and participated in a two-year follow-up study

✍ B. Winblad; K. Engedal; H. Soininen; F.R.J. Verhey; G. Waldemar; A. Wimo; A.-L. 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 286 KB

P.4.005 Functional improvement from trea

P.4.005 Functional improvement from treatment with the NMDA antagonist memantine: Results of a 28-week, randomized, placebo-controlled study in advanced Alzheimer's disease

✍ H.-J. Moebius; D. Galasko; B. Reisberg 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 133 KB

P4-337: Dimebon improves cognition, func

P4-337: Dimebon improves cognition, function, and behavior in mild and moderate Alzheimer's disease: Results by severity of a one-year, double-blind, placebo-controlled study

✍ Doody, Rachelle S.; Gavrilova, Svetlana; Thomas, Ronald; Aisen, Paul; Bachurin, 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 52 KB

544 EFFICACY OF EXTRACORPOREAL SHOCK WAV

544 EFFICACY OF EXTRACORPOREAL SHOCK WAVE THERAPY (ESWT) ON PLAQUE SIZE AND SEXUAL FUNCTION IN PATIENTS WITH PEYRONIE'S DISEASE (PD) - RESULTS OF A PROSPECTIVE, RANDOMIZED, PLACEBO-CONTROLLED STUDY

✍ G. Hatzichristodoulou; C. Meisner; A. Stenzl; S. Lahme 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 315 KB